ARCHIVES

NCI Advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 09 No. 30 | July 29, 1983

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of September

September 27, 2013

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988

Regulatory Agencies: HCFA Proposes Physician Transfer Of Drug Discounts To Medicare, Insurers

April 3, 1998

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995